Life Sciences
Hackers may have entered through one of its third-party vendors.
The Delaware-based company provides self-insured employers with data and strategies to reduce costs associated with prescription medications.
The company's new offerings will allow users to determine their cardiovascular age and overall cardiovascular health.
The companies will utilize Flatiron Clinical Pipe to connect electronic health records to electronic data capture for clinical trial data gathering.
Med-Gemini-3D can read 3D scans, generate radiology reports and answer questions, while Med-Gemini-Polygenic can predict health outcomes based on genomic data.
The Agency has qualified Apple's atrial fibrillation history feature as a medical device development tool, allowing it to be used in clinical trials.
The open-source gene editor is freely available to license for commercial use and ethical research.
The pharma giant's employees will have access to ChatGPT Enterprise, which allows teams to create customized GPTs on specific topics.
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.